VOTING RESULTS AND RESOLUTIONS OF THE ANNUAL GENERAL MEETING OF SHOP APOTHEKE EUROPE N.V. HELD AS A HYBRID MEETING ON 26 APRIL 2023
A total of 9,967,166 shares were represented at the annual general meeting of Shop Apotheke Europe N.V. (the "Company"), representing an equal number of votes to be exercised in respect of each of the voting items listed below. This represents 54.09% of the total issued and outstanding shares on the record date for the 2023 annual general meeting (i.e. on 29 March 2023), which amounted to 18,426,481 shares in bearer form. For each voting item all the potential numbers of valid votes were exercised. Percentages have been rounded.
Percentage of the | |||||||||||||||||||||||
Agenda | Description | For | Against | % | Abstain | total issued and | |||||||||||||||||
item | % | outstanding share | |||||||||||||||||||||
capital1 | |||||||||||||||||||||||
3.a. | Remuneration report for the financial year 20222 | 9,285,634 | 93.16 | 681,532 | 6.84 | 0 | 54.09 | ||||||||||||||||
3.c. | Adoption of the annual accounts for the financial year 2022 | 9,963,243 | 100 | 0 | 0 | 3,923 | 54.07 | ||||||||||||||||
3.e. | Proposal to allocate the results of the financial year 2022 | 9,967,146 | 100 | 0 | 0 | 20 | 54.09 | ||||||||||||||||
4.a. | Discharge from liability of all members of the managing board for the performance | 9,956,585 | 100 | 0 | 0 | 10,581 | 54.03 | ||||||||||||||||
of their duties during the past financial year | |||||||||||||||||||||||
4.b. | Discharge from liability of all members of the supervisory board for the performance | 9,956,585 | 100 | 0 | 0 | 10,581 | 54.03 | ||||||||||||||||
of their duties during the past financial year | |||||||||||||||||||||||
5.a. | Re-appointment of Mazars Accountants N.V. as external auditor of the Company to | 9,967,146 | 100 | 0 | 0 | 20 | 54.09 | ||||||||||||||||
audit the annual accounts of the Company for the financial year ending | |||||||||||||||||||||||
31 December 2023 | |||||||||||||||||||||||
6.a. | Re-appointment of Mr. Björn Söder as a member of the supervisory board | 9,713,979 | 97.46 | 253,167 | 2.54 | 20 | 54.09 | ||||||||||||||||
6.b. | Re-appointment of Mr. Frank Köhler as a member of the supervisory board | 9,086,260 | 91.16 | 880,886 | 8.84 | 20 | 54.09 | ||||||||||||||||
6.c. | Re-appointment of Mr. Jérôme Cochet as a member of the supervisory board | 9,714,156 | 97.46 | 252,990 | 2.54 | 20 | 54.09 | ||||||||||||||||
1
2
Percentage of the total number of votes for and against in relation to the total issued and outstanding share capital.
Shareholders who provided a positive advice, voted "for". Shareholders who voted "against", provided a negative advice with respect to the Company's remuneration report for the financial year 2022. The results of the vote on this agenda item counts as an advisory, non-binding, vote.
- 2 -
Percentage of the | |||||||||||||||||||||||
Agenda | Description | For | % | Against | % | Abstain | total issued and | ||||||||||||||||
item | outstanding share | ||||||||||||||||||||||
capital1 | |||||||||||||||||||||||
7.a. | Final discharge from liability of Mr. Stefan Feltens for the performance of his duties | 9,956,605 | 100 | 0 | 0 | 10,561 | 54.03 | ||||||||||||||||
as a member of the managing board | |||||||||||||||||||||||
7.b. | Appointment of Mr. Olaf Heinrich as a member of the managing board and CEO of | 9,385,846 | 94.17 | 581,300 | 5.83 | 20 | 54.09 | ||||||||||||||||
the Company | |||||||||||||||||||||||
7.c. | Re-appointment of Mr. Marc Fischer as a member of the managing board | 9,385,846 | 94.17 | 581,300 | 5.83 | 20 | 54.09 | ||||||||||||||||
7.d. | Re-appointment of Mr. Stephan Weber as a member of the managing board | 9,385,866 | 94.17 | 581,300 | 5.83 | 0 | 54.09 | ||||||||||||||||
7.e. | Re-appointment of Ms. Theresa Holler as a member of the managing board | 9,385,866 | 94.17 | 581,300 | 5.83 | 0 | 54.09 | ||||||||||||||||
8.a. | Approval and adoption of the 2023 stock option plan for the members of the | 9,936,704 | 99.69 | 30,462 | 0.31 | 0 | 54.09 | ||||||||||||||||
managing board to replace existing stock option plan for the members of the | |||||||||||||||||||||||
managing board | |||||||||||||||||||||||
9.a. | Designation of the supervisory board as the corporate body authorised to grant | 9,951,372 | 99.84 | 15,774 | 0.16 | 20 | 54.09 | ||||||||||||||||
(rights to acquire) shares under, pursuant to and in connection with the 2023 stock | |||||||||||||||||||||||
option plan for the members of the managing board | |||||||||||||||||||||||
9.b. | Designation of the managing board as the corporate body authorised to grant (rights | 7,908,159 | 79.34 | 2,059,007 | 20.66 | 0 | 54.09 | ||||||||||||||||
to acquire) shares under, pursuant to and in connection with the 2019 employee | |||||||||||||||||||||||
stock option plan | |||||||||||||||||||||||
10.a. | Prolongation of the authorisation of the managing board to repurchase shares in the | 9,967,166 | 100 | 0 | 0 | 0 | 54.09 | ||||||||||||||||
Company's own share capital | |||||||||||||||||||||||
11.a. | Amendment of the Company's articles of association to reflect the envisioned | 9,967,146 | 100 | 0 | 0 | 20 | 54.09 | ||||||||||||||||
change in the Company's statutory name | |||||||||||||||||||||||
12.a. | Amendment of the Company's remuneration policy to reflect certain changes | 4,841,915 | 49,15 | 5,009,507 | 50.85 | 115,744 | 53.46 | ||||||||||||||||
concerning the reimbursement of travel expenses and entitlements to committee | |||||||||||||||||||||||
membership fees | |||||||||||||||||||||||
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Shop Apotheke Europe NV published this content on 11 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 May 2023 15:23:08 UTC.